Sonnet BioTherapeutics Holdings, Inc.

NasdaqCM:SONN Stock Report

Market Cap: US$2.3m

Sonnet BioTherapeutics Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SONN?
Owner TypeNumber of SharesOwnership Percentage
Institutions4430.0649%
Individual Insiders45,2186.62%
General Public636,99893.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 119.2%.


Top Shareholders

Top 13 shareholders own 6.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.63%
John Markey
24,788US$84.9k0%no data
1.41%
Matthew Ruck
9,659US$33.1k0%no data
1.14%
Pankaj Mohan
7,816US$26.8k-0.08%no data
0.29%
Raghu Rao
1,983US$6.8k1.07%no data
0.055%
Tower Research Capital Europe Limited
378US$1.3k-57.8%no data
0.033%
John Cini
228US$780.6-0.44%no data
0.028%
Susan Dexter
191US$653.90%no data
0.025%
Nailesh Bhatt
174US$595.713.7%no data
0.024%
Albert Dyrness
164US$561.414.7%no data
0.02%
Jay Cross
136US$465.50%no data
0.0095%
BlackRock, Inc.
65US$222.50%no data
0.0085%
Donald Griffith
58US$198.745%no data
0.0031%
Lori McNeill
21US$72.00%no data